Figure 7f shows that there was significant upregulation of PD-1 expression in CD8+ T-cells treated with CPT-SAHA, alone or together with pre-siiRhom, suggesting a potential of combining with anti-PD-1 to further improve the cancer treatment. The gene discussed is CD8A; the disease is cancer.